Onesource Specialty Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2026 ,inter alia, to consider and approve the Audited Standalone ....
ONESOURCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
OneSource Specialty Pharma Limited has informed exchanges that a Board meeting is scheduled for May 13, 2026 to consider and approve the audited financial results (standalone and consolidated) for Q4 and the financial year ended March 31, 2026. The company has also closed its trading window for Designated Persons effective April 1, 2026, which will reopen 48 hours after the results are disseminated. This is a routine regulatory intimation under SEBI Listing Regulations — no financial figures or outcomes are disclosed at this stage.
No immediate stock impact expected; investors should note the trading window closure and await the results announcement on or after May 13, 2026.